Profile
Mark Hasleton worked as a Senior Director-Global New Therapeutic Entities at Teva Pharmaceutical Industries Ltd.
from 2010 to 2018.
He also worked as a Manager-EMEA Business Operations at Bristol Myers Squibb Co. He then worked as a Vice President-Business Development at Oramed Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Hasleton holds a doctorate from Imperial College London, a graduate degree from The University of Manchester, and an MBA from Imperial College Business School.
Former positions of Mark Hasleton
| Companies | Position | End |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Corporate Officer/Principal | 2019-08-26 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2017-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Mark Hasleton
| Imperial College London | Doctorate Degree |
| The University of Manchester | Graduate Degree |
| Imperial College Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
- Stock Market
- Insiders
- Mark Hasleton
